Back to top
more

Tenet Healthcare (THC)

(Delayed Data from NYSE)

$165.21 USD

165.21
1,128,110

-3.31 (-1.96%)

Updated Nov 8, 2024 04:00 PM ET

After-Market: $165.15 -0.06 (-0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 11% (28 out of 250)

Industry: Medical - Hospital

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Tenet (THC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

by Zacks Equity Research

Although the revenue and EPS for Tenet (THC) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Tenet Healthcare (THC) Beats Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Tenet (THC) delivered earnings and revenue surprises of 25.75% and 1.48%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Stay Ahead of the Game With Tenet (THC) Q3 Earnings: Wall Street's Insights on Key Metrics

by Zacks Equity Research

Besides Wall Street's top -and-bottom-line estimates for Tenet (THC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.

Kaibalya Pravo Dey headshot

A Dose of Growth? Why Tenet Healthcare Could be a Buy Pre-Q3 Earnings

by Kaibalya Pravo Dey

THC's third-quarter results are likely to reflect growing patient admissions, utilization and patient days.

Are Investors Undervaluing Tenet Healthcare (THC) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

HCA Healthcare (HCA) Beats Q3 Earnings Estimates

by Zacks Equity Research

HCA (HCA) delivered earnings and revenue surprises of 1.61% and 0.04%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Investors Heavily Search Tenet Healthcare Corporation (THC): Here is What You Need to Know

by Zacks Equity Research

Zacks.com users have recently been watching Tenet (THC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Community Health Systems (CYH) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Community Health Systems (CYH) delivered earnings and revenue surprises of -87.50% and 0.25%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Acadia Healthcare (ACHC) Q3 Earnings Expected to Decline

by Zacks Equity Research

Acadia Healthcare (ACHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Tenet Healthcare (THC) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Tenet (THC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Tenet Healthcare (THC) Surpasses Market Returns: Some Facts Worth Knowing

by Zacks Equity Research

In the latest trading session, Tenet Healthcare (THC) closed at $163.87, marking a +1.34% move from the previous day.

Kaibalya Pravo Dey headshot

Bargain or Bust? Decoding Tenet Healthcare Stock's Lower Valuation

by Kaibalya Pravo Dey

THC is well-positioned to benefit from the growing demand for hospital services. Yet, rising costs can potentially squeeze its margin growth.

Here's Why Tenet Healthcare (THC) is a Strong Value Stock

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Tenet Healthcare (THC) Declines More Than Market: Some Information for Investors

by Zacks Equity Research

In the latest trading session, Tenet Healthcare (THC) closed at $161.71, marking a -1.41% move from the previous day.

Here's Why Tenet Healthcare (THC) is a Strong Momentum Stock

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Why Tenet Healthcare (THC) is a Top Growth Stock for the Long-Term

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Tenet Healthcare (THC) Surpasses Market Returns: Some Facts Worth Knowing

by Zacks Equity Research

Tenet Healthcare (THC) closed at $155.82 in the latest trading session, marking a +1.99% move from the prior day.

Brookdale Q3 2024 Occupancy Jumps, Logs 35th Straight Monthly Boost

by Zacks Equity Research

BKD's weighted average occupancy for September grows 30 bps sequentially.

Tenet Healthcare (THC) Sees a More Significant Dip Than Broader Market: Some Facts to Know

by Zacks Equity Research

In the closing of the recent trading day, Tenet Healthcare (THC) stood at $152.78, denoting a -0.84% change from the preceding trading day.

Community Health Teams Up With Denim to Scale Conversational AI

by Zacks Equity Research

With this move, CYH intends to streamline agent workload, which can result in more savings for the company.

Here is What to Know Beyond Why Tenet Healthcare Corporation (THC) is a Trending Stock

by Zacks Equity Research

Zacks.com users have recently been watching Tenet (THC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Debasmita Chatterjee headshot

Does Universal Health's Low P/E Ratio Signal a Suitable Entry Point?

by Debasmita Chatterjee

UHS rides on increased patient volumes. It can effectively cater to its patients through its extensive treatment network.

Merit Medical Stock Gains 24.7% Year to Date: What's Behind the Rally?

by Zacks Equity Research

MMSI shows strong growth momentum with a robust product portfolio and recent acquisitions, positioning itself well in competitive healthcare markets.

Trinity Biotech Shares Surge on Positive Pre-Pivotal Clinical CGM Trial

by Zacks Equity Research

TRIB announces positive results from its pre-pivotal clinical European trial for a next-gen continuous glucose monitor, setting the stage for further development in 2025.

Here's Why You Should Retain CONMED Stock in Your Portfolio

by Zacks Equity Research

CNMD is poised for growth with strong product offerings and recurring revenues but faces headwinds from regulatory challenges, supply-chain constraints and cybersecurity risks.